Estrogen and Selective Estrogen Receptor Modulators: Neuroprotection in the Women's Health Initiative Era

Author： Murphy Stephanie J.   McCullough Louise D.   Littleton-Kearney Marguerite T.   Hurn Patricia D.  

Publisher： Humana Press, Inc

ISSN： 0969-711X

Source： Endocrine Journal, Vol.21, Iss.1, 2003-06, pp. : 17-26

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Selective Estrogen Receptor Modulators and Coronary Heart Disease

By Bian Z.   Nilsson S.   Gustafsson J.-.  

Trends in Cardiovascular Medicine, Vol. 11, Iss. 5, 2001-07 ,pp. : 196-202

Elsevier

Access to resources Recommend Favorite

Effects of Raloxifene, One of the Selective Estrogen Receptor Modulators, on Pituitary–Ovary Axis and Prolactin in Postmenopausal Women

By Cheng Wern-Cherng   Yen Men-Lu   Hsu Sandy H. J.   Chen Kuang-Ho   Tsai Keh-Sung  

Endocrine Journal, Vol. 23, Iss. 2-3, 2004-03 ,pp. : 215-218

Humana Press, Inc

Access to resources Recommend Favorite

Hormone Replacement Therapy, Selective Estrogen Receptor Modulators, and Tissue-Specific Compounds: Cardiovascular Effects and Clinical Implications

By Vogelvang Tatjana E.   Marius J. van der Mooren   Mijatovic Velja  

Treatments in Endocrinology, Vol. 3, Iss. 2, 2004-01 ,pp. : 105-115

Adis International

Access to resources Recommend Favorite

The effect of medroxyprogesterone acetate on estrogen-dependent risks and benefits – an attempt to interpret the Women's Health Initiative results

By Kuhl Herbert   Stevenson John  

Gynecological Endocrinology, Vol. 22, Iss. 6, 2006-06 ,pp. : 303-317

Informa Healthcare

Access to resources Recommend Favorite

Functional Aspects of Estrogen Neuroprotection

By Bisagno Veronica   Bowman Rachel E.   Luine Victoria N.  

Endocrine Journal, Vol. 21, Iss. 1, 2003-06 ,pp. : 33-42

Humana Press, Inc

Access to resources Recommend Favorite